A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. - Wikidata - wikimedia - TriplyDB

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

http://www.wikidata.org/entity/Q34282319

about

Novel agents for chronic lymphocytic leukemia Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Alemtuzumab for patients with chronic lymphocytic leukaemia Chlorambucil for the treatment of patients with chronic lymphocytic leukaemia, or small lymphocytic lymphoma Bendamustine for patients with B cell lymphoid malignancies Alemtuzumab for chronic lymphocytic leukaemia Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Purine Antagonists for Chronic Lymphocytic Leukaemia Purine Antagonists for Chronic Lymphocytic Leukaemia Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia Chronic lymphocytic leukemia: a clinical review including Korean cohorts Current concepts in diagnosis and treatment of chronic lymphocytic leukemia Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia Clinical implications of the molecular genetics of chronic lymphocytic leukemia Immunological aspects in chronic lymphocytic leukemia (CLL) development Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification An update on the management of chronic lymphocytic leukaemia.Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.Genomic data integration in chronic lymphocytic leukemia.Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients.Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.

P2860

Q21198858-2DA6A8BA-CE14-453B-869B-8E6531296CAF Q23917829-71918B50-D9BF-4448-BC4D-8A3EF276C619 Q24186840-A706B6A4-DD4D-4775-BC69-F9DE09AC3A40 Q24198941-0C739D9A-AC86-40DC-B00E-A6BD281333A0 Q24200280-42706E18-4F05-4E72-AFD5-EB44F29917AB Q24203027-214336C5-6A07-41F5-B690-DE57D3EE75F1 Q24203628-7EC2B4E2-5D53-4F55-8583-EAEEDA1BA37D Q24236385-FA0E7D03-DC3C-4B6E-9240-AB154C9C261E Q24236426-124A2453-6BC4-4376-87BC-F53BB19E0805 Q24240922-7C8C39BF-6882-4437-89E6-48B47E99426B Q24241519-44780473-775A-483F-80F9-DEA5F18F0B73 Q24245132-11CB1DCC-A457-48C9-A4F7-68FED4AFFC6F Q24248167-0F8483CB-A9EA-4B8A-A894-AA7AE92F89D1 Q24616084-13018671-70CA-49E0-9E45-598A426C6BC4 Q24657747-7F6A518E-2472-44F4-AAA9-AAFBB53E29C1 Q26751006-BAB886F5-37F6-4DAE-93DE-CEA7DFF9BD75 Q26752467-10E7F343-8A9B-446D-B962-51BBDB03EF4E Q26770471-9E0F1D97-9428-45A4-BC4E-4EEF7A5940D8 Q26775986-03596F5E-4055-48C6-BCAF-FC6D9CFA7093 Q26801292-401FF2E5-293C-4CBF-8DAF-CA9DB394BFAA Q26830323-C1CCF9B1-F876-4E10-B6F8-7758BEE90A22 Q26830955-F7B246E4-2772-4C39-8087-E2E8B9483822 Q26865940-38D0C1E5-583B-47D4-ADA7-85DBB973C463 Q28082086-C9E1B4A3-559A-476F-B60F-F5295AAA2B87 Q28082120-D4705019-AAAD-436C-BFC5-0D26EB99F38F Q30341946-AEE5339B-598A-41F8-9E09-BFDD581885A7 Q30661281-E90E70AF-0A5F-4D55-A3D7-1FBA7268DB1B Q30801095-F2AC8C8C-28AA-4D9A-BBF9-7791A1960AD6 Q31147488-858D5AAB-A7D4-4747-8B3B-AC096F229FBF Q33338763-5EF52A21-FB3C-49E6-998B-0B9BC930A71A Q33346607-346D6C38-FC3D-45AA-A02F-51ADF7EEB42F Q33364071-514F5B40-1825-4BA8-8A86-8D87DC90355A Q33367301-7BA5507B-D25E-487E-A27F-A71E40757380 Q33379107-31F6E245-A01E-4457-99E4-8A238DDC68D2 Q33384585-226CA875-8890-4C24-BE0F-4F1D8A4C1B90 Q33386533-6CE7010E-45BF-4C32-AEE2-A48B9656F1F5 Q33390656-517CB424-B099-47F6-988D-114D41A43448 Q33401394-4590316F-343D-4809-8F31-505004AA9357 Q33405017-0807E5CE-709A-47D4-B4EE-D9C161987118 Q33406598-41EAC4A4-A6DC-430D-926D-7B6A609C3F34

P2860

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

http://www.wikidata.org/entity/Q34282319

description

1981 nî lūn-bûn

@nan

1981 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1981 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1981年の論文

@ja

1981年論文

@yue

1981年論文

@zh-hant

1981年論文

@zh-hk

1981年論文

@zh-mo

1981年論文

@zh-tw

1981年论文

@wuu

name

A new prognostic classificatio ...... ultivariate survival analysis.

@ast

A new prognostic classificatio ...... ultivariate survival analysis.

@en

A new prognostic classificatio ...... ultivariate survival analysis.

@nl

type

label

A new prognostic classificatio ...... ultivariate survival analysis.

@ast

A new prognostic classificatio ...... ultivariate survival analysis.

@en

A new prognostic classificatio ...... ultivariate survival analysis.

@nl

prefLabel

A new prognostic classificatio ...... ultivariate survival analysis.

@ast

A new prognostic classificatio ...... ultivariate survival analysis.

@en

A new prognostic classificatio ...... ultivariate survival analysis.

@nl

P1433

Q34282319-8AC825BC-F937-4383-8FCF-8D480F6848C0

P1476

Q34282319-4F6B3D57-60F5-46A0-9AC7-195AF98CD23A

P2093

Q34282319-0E279A4A-A9A3-4089-ADC1-D6DCA74C168D

Q34282319-13CE4064-BFB0-4F87-BC36-F6C1D2C23ECE

Q34282319-13F1ED42-47ED-4D48-B5D8-5BEC4F0720F1

Q34282319-2C02B6D0-FE14-4B37-90D6-70A38BC8508D

Q34282319-2F204217-D53E-4846-B968-6B526DC6DC71

Q34282319-35CDF5C9-D0AE-4AF1-8ACB-5F45873BC6FD

Q34282319-378951ED-2668-4765-8065-05BB489333C6

Q34282319-4F7DB03E-3FB8-4B21-99FC-8E57CE60F835

Q34282319-7A865222-9025-4D64-BE17-1F08B9E8AE9E

Q34282319-7DC3049E-668D-4A90-9418-7C94B82967BE

P304

Q34282319-035B160A-E6D2-464B-911D-2F2A1150BEFE

P31

Q34282319-A2C50B8B-0323-4BB7-B9A7-5FA9731FE8A3

P356

Q34282319-E4DE352F-C11D-42B2-9584-EB93F065B258

P407

Q34282319-58EFC828-07D7-4C11-BCE3-A0735D841DEA

P433

Q34282319-1E19F2A6-CFA4-4EB7-9F66-8211CAA0DDEA

P478

Q34282319-9BC5259C-750A-4D84-A238-F624E03AB1DE

P577

Q34282319-20F9039D-7DA6-4B3E-8316-DE0440885884

P698

Q34282319-34BD0B6F-8580-4419-BD02-8C5167D36C36

P921

Q34282319-86E276CD-905B-411C-B422-EFC982FF33E3

Q34282319-ABEE7505-E849-447D-9BDB-BB7947699756

P356

1097-0142(19810701)48:1%3C198::AID-CNCR2820480131%3E3.0.CO;2-V

P1433

P1476

A new prognostic classificatio ...... ultivariate survival analysis.

@en

P2093

Auquier A

http://www.w3.org/2001/XMLSchema#string

Belabbes S

http://www.w3.org/2001/XMLSchema#string

Binet JL

http://www.w3.org/2001/XMLSchema#string

Boivin P

http://www.w3.org/2001/XMLSchema#string

Chastang C

http://www.w3.org/2001/XMLSchema#string

Colona P

http://www.w3.org/2001/XMLSchema#string

Dighiero G

http://www.w3.org/2001/XMLSchema#string

Duault MT

http://www.w3.org/2001/XMLSchema#string

Goasguen J

http://www.w3.org/2001/XMLSchema#string

Gremy F

http://www.w3.org/2001/XMLSchema#string

P304

198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

1981-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7237385

http://www.w3.org/2001/XMLSchema#string

P921